The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Organs and Bionic Implants Market Research Report 2025
Synopsis
An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person.
The global Artificial Organs and Bionic Implants market was valued at US$ 9143 million in 2023 and is anticipated to reach US$ 15080 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North America is the largest market of Artificial Organs And Bionic Implants, with a share about 45%, followed by Europe and China, both have a share about 50 percent. Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%.
This report aims to provide a comprehensive presentation of the global market for Artificial Organs and Bionic Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Organs and Bionic Implants.
Report Scope
The Artificial Organs and Bionic Implants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Organs and Bionic Implants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Organs and Bionic Implants companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Medical Care
Cochlear
Abiomed
ABBOTT
Baxter
B.Braun
Asahi Kasei Corporation
Nipro
MED-EL
Toray Medical
Sonova
Medtronic
Getinge (Maquet)
William Demant
LivaNova (Sorin)
Terumo
Hangzhou Nurotron
Syncardia
CorWave
Listent Medical
Evaheart
Open Bionics
OYMotion Technologies
Mobius Bionics
Segment by Type
Artificial Kidney
Artificial Heart & Ventricular Assist Device
Cochlear Implant
Artificial Lung
Artificial Liver
Artificial Pancreas
Bionic Hands & Prosthetics
Others
Segment by Application
Commercialize
Clinical Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Organs and Bionic Implants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person.
The global Artificial Organs and Bionic Implants market was valued at US$ 9143 million in 2023 and is anticipated to reach US$ 15080 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North America is the largest market of Artificial Organs And Bionic Implants, with a share about 45%, followed by Europe and China, both have a share about 50 percent. Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%.
This report aims to provide a comprehensive presentation of the global market for Artificial Organs and Bionic Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Organs and Bionic Implants.
Report Scope
The Artificial Organs and Bionic Implants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Organs and Bionic Implants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Organs and Bionic Implants companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Medical Care
Cochlear
Abiomed
ABBOTT
Baxter
B.Braun
Asahi Kasei Corporation
Nipro
MED-EL
Toray Medical
Sonova
Medtronic
Getinge (Maquet)
William Demant
LivaNova (Sorin)
Terumo
Hangzhou Nurotron
Syncardia
CorWave
Listent Medical
Evaheart
Open Bionics
OYMotion Technologies
Mobius Bionics
Segment by Type
Artificial Kidney
Artificial Heart & Ventricular Assist Device
Cochlear Implant
Artificial Lung
Artificial Liver
Artificial Pancreas
Bionic Hands & Prosthetics
Others
Segment by Application
Commercialize
Clinical Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Organs and Bionic Implants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Organs and Bionic Implants Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Artificial Kidney
1.2.3 Artificial Heart & Ventricular Assist Device
1.2.4 Cochlear Implant
1.2.5 Artificial Lung
1.2.6 Artificial Liver
1.2.7 Artificial Pancreas
1.2.8 Bionic Hands & Prosthetics
1.2.9 Others
1.3 Market by Application
1.3.1 Global Artificial Organs and Bionic Implants Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercialize
1.3.3 Clinical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Organs and Bionic Implants Market Perspective (2019-2030)
2.2 Artificial Organs and Bionic Implants Growth Trends by Region
2.2.1 Global Artificial Organs and Bionic Implants Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Organs and Bionic Implants Historic Market Size by Region (2019-2024)
2.2.3 Artificial Organs and Bionic Implants Forecasted Market Size by Region (2025-2030)
2.3 Artificial Organs and Bionic Implants Market Dynamics
2.3.1 Artificial Organs and Bionic Implants Industry Trends
2.3.2 Artificial Organs and Bionic Implants Market Drivers
2.3.3 Artificial Organs and Bionic Implants Market Challenges
2.3.4 Artificial Organs and Bionic Implants Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Organs and Bionic Implants Players by Revenue
3.1.1 Global Top Artificial Organs and Bionic Implants Players by Revenue (2019-2024)
3.1.2 Global Artificial Organs and Bionic Implants Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Organs and Bionic Implants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Organs and Bionic Implants Revenue
3.4 Global Artificial Organs and Bionic Implants Market Concentration Ratio
3.4.1 Global Artificial Organs and Bionic Implants Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Organs and Bionic Implants Revenue in 2023
3.5 Artificial Organs and Bionic Implants Key Players Head office and Area Served
3.6 Key Players Artificial Organs and Bionic Implants Product Solution and Service
3.7 Date of Enter into Artificial Organs and Bionic Implants Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Organs and Bionic Implants Breakdown Data by Type
4.1 Global Artificial Organs and Bionic Implants Historic Market Size by Type (2019-2024)
4.2 Global Artificial Organs and Bionic Implants Forecasted Market Size by Type (2025-2030)
5 Artificial Organs and Bionic Implants Breakdown Data by Application
5.1 Global Artificial Organs and Bionic Implants Historic Market Size by Application (2019-2024)
5.2 Global Artificial Organs and Bionic Implants Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Organs and Bionic Implants Market Size (2019-2030)
6.2 North America Artificial Organs and Bionic Implants Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Organs and Bionic Implants Market Size by Country (2019-2024)
6.4 North America Artificial Organs and Bionic Implants Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Organs and Bionic Implants Market Size (2019-2030)
7.2 Europe Artificial Organs and Bionic Implants Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Organs and Bionic Implants Market Size by Country (2019-2024)
7.4 Europe Artificial Organs and Bionic Implants Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Organs and Bionic Implants Market Size (2019-2030)
8.2 Asia-Pacific Artificial Organs and Bionic Implants Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Organs and Bionic Implants Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Organs and Bionic Implants Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Organs and Bionic Implants Market Size (2019-2030)
9.2 Latin America Artificial Organs and Bionic Implants Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Organs and Bionic Implants Market Size by Country (2019-2024)
9.4 Latin America Artificial Organs and Bionic Implants Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Organs and Bionic Implants Market Size (2019-2030)
10.2 Middle East & Africa Artificial Organs and Bionic Implants Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Detail
11.1.2 Fresenius Medical Care Business Overview
11.1.3 Fresenius Medical Care Artificial Organs and Bionic Implants Introduction
11.1.4 Fresenius Medical Care Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.1.5 Fresenius Medical Care Recent Development
11.2 Cochlear
11.2.1 Cochlear Company Detail
11.2.2 Cochlear Business Overview
11.2.3 Cochlear Artificial Organs and Bionic Implants Introduction
11.2.4 Cochlear Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.2.5 Cochlear Recent Development
11.3 Abiomed
11.3.1 Abiomed Company Detail
11.3.2 Abiomed Business Overview
11.3.3 Abiomed Artificial Organs and Bionic Implants Introduction
11.3.4 Abiomed Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.3.5 Abiomed Recent Development
11.4 ABBOTT
11.4.1 ABBOTT Company Detail
11.4.2 ABBOTT Business Overview
11.4.3 ABBOTT Artificial Organs and Bionic Implants Introduction
11.4.4 ABBOTT Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.4.5 ABBOTT Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Artificial Organs and Bionic Implants Introduction
11.5.4 Baxter Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.5.5 Baxter Recent Development
11.6 B.Braun
11.6.1 B.Braun Company Detail
11.6.2 B.Braun Business Overview
11.6.3 B.Braun Artificial Organs and Bionic Implants Introduction
11.6.4 B.Braun Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.6.5 B.Braun Recent Development
11.7 Asahi Kasei Corporation
11.7.1 Asahi Kasei Corporation Company Detail
11.7.2 Asahi Kasei Corporation Business Overview
11.7.3 Asahi Kasei Corporation Artificial Organs and Bionic Implants Introduction
11.7.4 Asahi Kasei Corporation Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.7.5 Asahi Kasei Corporation Recent Development
11.8 Nipro
11.8.1 Nipro Company Detail
11.8.2 Nipro Business Overview
11.8.3 Nipro Artificial Organs and Bionic Implants Introduction
11.8.4 Nipro Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.8.5 Nipro Recent Development
11.9 MED-EL
11.9.1 MED-EL Company Detail
11.9.2 MED-EL Business Overview
11.9.3 MED-EL Artificial Organs and Bionic Implants Introduction
11.9.4 MED-EL Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.9.5 MED-EL Recent Development
11.10 Toray Medical
11.10.1 Toray Medical Company Detail
11.10.2 Toray Medical Business Overview
11.10.3 Toray Medical Artificial Organs and Bionic Implants Introduction
11.10.4 Toray Medical Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.10.5 Toray Medical Recent Development
11.11 Sonova
11.11.1 Sonova Company Detail
11.11.2 Sonova Business Overview
11.11.3 Sonova Artificial Organs and Bionic Implants Introduction
11.11.4 Sonova Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.11.5 Sonova Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic Artificial Organs and Bionic Implants Introduction
11.12.4 Medtronic Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.12.5 Medtronic Recent Development
11.13 Getinge (Maquet)
11.13.1 Getinge (Maquet) Company Detail
11.13.2 Getinge (Maquet) Business Overview
11.13.3 Getinge (Maquet) Artificial Organs and Bionic Implants Introduction
11.13.4 Getinge (Maquet) Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.13.5 Getinge (Maquet) Recent Development
11.14 William Demant
11.14.1 William Demant Company Detail
11.14.2 William Demant Business Overview
11.14.3 William Demant Artificial Organs and Bionic Implants Introduction
11.14.4 William Demant Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.14.5 William Demant Recent Development
11.15 LivaNova (Sorin)
11.15.1 LivaNova (Sorin) Company Detail
11.15.2 LivaNova (Sorin) Business Overview
11.15.3 LivaNova (Sorin) Artificial Organs and Bionic Implants Introduction
11.15.4 LivaNova (Sorin) Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.15.5 LivaNova (Sorin) Recent Development
11.16 Terumo
11.16.1 Terumo Company Detail
11.16.2 Terumo Business Overview
11.16.3 Terumo Artificial Organs and Bionic Implants Introduction
11.16.4 Terumo Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.16.5 Terumo Recent Development
11.17 Hangzhou Nurotron
11.17.1 Hangzhou Nurotron Company Detail
11.17.2 Hangzhou Nurotron Business Overview
11.17.3 Hangzhou Nurotron Artificial Organs and Bionic Implants Introduction
11.17.4 Hangzhou Nurotron Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.17.5 Hangzhou Nurotron Recent Development
11.18 Syncardia
11.18.1 Syncardia Company Detail
11.18.2 Syncardia Business Overview
11.18.3 Syncardia Artificial Organs and Bionic Implants Introduction
11.18.4 Syncardia Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.18.5 Syncardia Recent Development
11.19 CorWave
11.19.1 CorWave Company Detail
11.19.2 CorWave Business Overview
11.19.3 CorWave Artificial Organs and Bionic Implants Introduction
11.19.4 CorWave Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.19.5 CorWave Recent Development
11.20 Listent Medical
11.20.1 Listent Medical Company Detail
11.20.2 Listent Medical Business Overview
11.20.3 Listent Medical Artificial Organs and Bionic Implants Introduction
11.20.4 Listent Medical Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.20.5 Listent Medical Recent Development
11.21 Evaheart
11.21.1 Evaheart Company Detail
11.21.2 Evaheart Business Overview
11.21.3 Evaheart Artificial Organs and Bionic Implants Introduction
11.21.4 Evaheart Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.21.5 Evaheart Recent Development
11.22 Open Bionics
11.22.1 Open Bionics Company Detail
11.22.2 Open Bionics Business Overview
11.22.3 Open Bionics Artificial Organs and Bionic Implants Introduction
11.22.4 Open Bionics Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.22.5 Open Bionics Recent Development
11.23 OYMotion Technologies
11.23.1 OYMotion Technologies Company Detail
11.23.2 OYMotion Technologies Business Overview
11.23.3 OYMotion Technologies Artificial Organs and Bionic Implants Introduction
11.23.4 OYMotion Technologies Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.23.5 OYMotion Technologies Recent Development
11.24 Mobius Bionics
11.24.1 Mobius Bionics Company Detail
11.24.2 Mobius Bionics Business Overview
11.24.3 Mobius Bionics Artificial Organs and Bionic Implants Introduction
11.24.4 Mobius Bionics Revenue in Artificial Organs and Bionic Implants Business (2019-2024)
11.24.5 Mobius Bionics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
